Charles Schwab Investment Management Inc Renovo Rx, Inc. Transaction History
Charles Schwab Investment Management Inc
- $519 Billion
- Q2 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Renovo Rx, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 49,232 shares of RNXT stock, worth $50,216. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49,232
Previous 49,232
-0.0%
Holding current value
$50,216
Previous $65,000
15.38%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding RNXT
# of Institutions
19Shares Held
1.87MCall Options Held
0Put Options Held
0-
Bank Of The West975KShares$994,5000.27% of portfolio
-
Adar1 Capital Management, LLC Austin, TX355KShares$362,3440.08% of portfolio
-
Geode Capital Management, LLC Boston, MA144KShares$146,7970.0% of portfolio
-
Nixon Peabody Trust CO Boston, MA97.2KShares$99,1080.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny86.3KShares$88,0420.0% of portfolio
About RenovoRx, Inc.
- Ticker RNXT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 9,066,860
- Market Cap $9.25M
- Description
- RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, In...